Sitemap
April 10, 2019 Articles
Filter by Available Specialty
- ACC prevention highlights: New guideline, benefits of statin alternative, prescription fish oil
- ACP Internal Medicine Meeting highlights clinical, practice management updates
- Active treatment improves survival in smallest US babies
- Adding bismuth to triple therapy boosts H. pylori eradication
- Adiposity may have protective effect in young adults with acne
- Advances in chronic lymphocytic leukemia suggest progress is ‘visible on the horizon’
- AGTC announces enrollment milestones in two gene therapy trials
- Antibiotic-loaded bone cement did not reduce infection rate in TJA
- Bleeding, ischemic risk increased in high-risk patients after PCI
- BLOG: Why private equity matters
- Blood flow restriction therapy may minimize muscle, bone loss after ACL reconstruction
- Cancer Treatment Centers of America appoints president, CEO
- Company executives, medical professionals charged in large health care fraud scheme
- Daily cannabis use more common among people with psychological distress
- Disease-related costs decrease after GERD procedure
- Don’t miss opportunities to improve service
- FDA grants breakthrough therapy designation for ticagrelor reversal agent
- FDA takes steps to limit use of fentanyl products
- Flavis partners with the NKF to promote medical nutrition therapy for CKD
- Former NFL players have more Alzheimer’s protein markers than non-athletes
- Full-thickness corneal transplants with cataract surgery still have a role
- Graphic narratives may improve patient comprehension, reduce anxiety before coronary angiography
- Houston hospital saw no increase in mold infections after Hurricane Harvey
- Immunotherapy for head and neck cancer an evolving paradigm
- Is ibrutinib-based therapy the preferred initial treatment for all patients with CLL?
- IV fosfomycin effective in treating complicated UTIs
- Laser, electrosurgery justified when other anogenital wart treatments fail
- Liver cancer mortality more common among those with lower education
- Lost productivity, indirect costs substantial after ACS, stroke in Europe
- Machine learning algorithm may diagnose thyroid nodules better than radiologists
- Manufacturers, PBMs testify to 'broken system' behind high insulin prices
- Neoadjuvant pembrolizumab confers survival benefit among patients with glioblastoma
- New PsA therapies not superior to established treatments, lag behind psoriasis responses
- Novel technique seen as effective treatment for habitual patellar dislocations in skeletally mature patients
- Ocugen, Histogenics to merge
- Pembrolizumab granted priority review for three oncology indications
- Phase 0 trials ‘quickest route’ for development of glioblastoma treatments
- Physicians favor pediatric antimicrobial stewardship but question its efficiency
- Placebo-controlled, relapse prevention trials in schizophrenia may be unnecessary
- Readmission rates for patients with HF similar in U.S., Canada
- Resistant hypertension twice as common in patients with SLE
- RPA presents special awards at annual meeting
- Sanofi expands savings plan to offer $99 monthly insulin
- Studies show varying efficacy of immunotherapy in elderly patients with lung cancer
- Swift response kept humans safe during ‘massive’ anthrax outbreak in wildlife
- The potential benefits (and pitfalls) of real-world evidence in oncology
- Top stories in endocrinology: Men with hypogonadism have new testosterone therapy choices, plan caps out-of-pocket insulin costs
- Treatment response in AML: Understanding available molecular diagnostic data
- T-score 'key indicator' of fracture risk after long-term denosumab treatment